Equity Profile

BDX

Becton, Dickinson and Company

Health CareHealth Care Equipment$42.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ3-2026Pre-Market9:00 AM EDT

Company Snapshot

Becton, Dickinson and Company (BDX) is a leading global medical technology company that develops and manufactures a wide range of medical devices, instrument systems, and reagents. Operating in the health care sector, BDX plays a crucial role in improving patient care and safety, particularly in areas like diagnostics and medication management.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and innovate, which is essential for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BDX Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+4.98%

Avg Stock Reaction

-1.31%

Last Quarter Recap

In Q2-2026, BDX reported an EPS of $2.90, beating expectations by 4.73%. The stock reacted positively, gaining 5.87% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of BDX's earnings report, given the company's strong track record of beating EPS estimates. However, the lack of revenue guidance adds uncertainty.

Bull Case

If BDX continues its trend of beating EPS estimates, it could signal strong operational performance and potentially lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the recent volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026?

The market is keenly focused on whether BDX can maintain its streak of beating EPS estimates, which could significantly impact investor sentiment.

What are the revenue trends in key product segments?

Understanding revenue performance in critical areas will provide insight into the company's growth prospects and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating BDX's ability to outperform expectations due to its strong historical performance and recent operational improvements.

Supporting Evidence

BDX has consistently beaten EPS estimates, achieving a 100% beat rate over the last eight quarters.

The stock has shown resilience in previous quarters, often recovering quickly from initial declines.

Key Risk

If BDX reports an EPS significantly above $3.00, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether BDX can continue its positive earnings momentum amidst a challenging market environment.

Bull Confirmed If

An EPS of $3.00 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $2.70 would confirm the bear case, suggesting potential issues in revenue generation or cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±12.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±12.0% while BDX has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

32.1%

Calls (185K)P/C Ratio: 0.46Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BDX beats expectations, history suggests a potential stock increase of around 5.41%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

A miss could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 1.31%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the pipeline.
2Insights into cost management strategies and their impact on margins.
3Details on market share changes in key segments.
4Management's outlook on industry trends and competitive pressures.
5Any commentary on supply chain stability and its effects on operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and innovate, which is essential for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BDX Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+4.98%

Avg Stock Reaction

-1.31%

Last Quarter Recap

In Q2-2026, BDX reported an EPS of $2.90, beating expectations by 4.73%. The stock reacted positively, gaining 5.87% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of BDX's earnings report, given the company's strong track record of beating EPS estimates. However, the lack of revenue guidance adds uncertainty.

Bull Case

If BDX continues its trend of beating EPS estimates, it could signal strong operational performance and potentially lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the recent volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026?

The market is keenly focused on whether BDX can maintain its streak of beating EPS estimates, which could significantly impact investor sentiment.

What are the revenue trends in key product segments?

Understanding revenue performance in critical areas will provide insight into the company's growth prospects and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating BDX's ability to outperform expectations due to its strong historical performance and recent operational improvements.

Supporting Evidence

BDX has consistently beaten EPS estimates, achieving a 100% beat rate over the last eight quarters.

The stock has shown resilience in previous quarters, often recovering quickly from initial declines.

Key Risk

If BDX reports an EPS significantly above $3.00, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether BDX can continue its positive earnings momentum amidst a challenging market environment.

Bull Confirmed If

An EPS of $3.00 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $2.70 would confirm the bear case, suggesting potential issues in revenue generation or cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±12.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±12.0% while BDX has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

32.1%

Calls (185K)P/C Ratio: 0.46Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BDX beats expectations, history suggests a potential stock increase of around 5.41%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

A miss could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 1.31%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the pipeline.
2Insights into cost management strategies and their impact on margins.
3Details on market share changes in key segments.
4Management's outlook on industry trends and competitive pressures.
5Any commentary on supply chain stability and its effects on operations.